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WW domains are recently described protein–protein
interaction modules; they bind to proline-rich
sequences that usually also contain a tyrosine. These
domains have been detected in several unrelated
proteins, often alongside other domains. Recent
studies suggest that WW domains in specific proteins
may play a role in diseases such as hypertension or
muscular dystrophy.
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The WW domain, also known as the WWP or Rsp5 domain
[1–3], is a ~40 amino acid protein module recently identi-
fied in a variety of unrelated proteins (for example, dys-
trophin, Nedd4/Rsp5, YAP65) and is often found alongside
other known domains (Fig. 1). It therefore joins a family of
domains that includes SH2, SH3, PH/PTB/PID, C2 and
other protein–protein or protein–lipid interaction modules
(for a review, see [4,5]). The domain contains two highly
conserved tryptophans and an invariant proline (Fig. 2),
hence the name WW (WWP) domain. WW domains are
often present in multiple copies in a protein (for example,
in Rsp5/Nedd4 or in the mouse YAP65; Fig. 1), but
sequence similarity, in some cases, is greater between WW
domains of different proteins than between WW domains
within the same protein [6]. This suggests a unique role for
individual WW domains when present in multiple copies.
Although classification of the various known WW domains
is preliminary, phylogenetic distance analysis [6] and
recent binding studies (see below) suggest that the Nedd4
and YAP65 WW domains belong to a different sub-
class from the dystrophin WW domain. Little is known
about the function of WW domains, but recent evi-
dence described below implicates this domain as a
protein–protein interaction module which functions analo-
gous to, but distinct from, SH3 domains.
WW ligands: the PY motif
Chen and Sudol [7] have recently demonstrated in vitro
association of the YAP65 (yes-associated protein) WW
domain with short proline-rich repeats also containing a
tyrosine (PPPPY) in the proteins WBP1 and WBP2. They
then proposed the PY motif (xPPxY, where x is any amino
acid) as a preliminary consensus for WW domain binding.
Similar proline-rich PY motifs recently identified in the
epithelial Na+ channel (ENaC) [8,9] were shown to associ-
ate in vitro and in living cells with the WW domains of
Nedd4 [8]. In the latter, each of the three subunits of the
channel (a, b and g, ENaC) contains a single PY motif
located at the C terminus (PPPAY, PPPNY, PPP(R/K)Y,
for a, b and g ENaC, respectively). The biological signifi-
cance of these ENaC–Nedd4 interactions is discussed
below. PY motifs have been identified in many other
unrelated proteins, such as viral gag proteins, interleukin
receptors and several serine/threonine kinases [10], but
the significance of these occurrences has still to be deter-
mined. The PY motif differs from SH3-binding (xPpxP,
where p is usually also a Pro) motifs [4,11], and accord-
ingly, preliminary in vitro binding studies indicate it does
not bind SH3-domains [7,8]. However, exceptions may
exist, as the proline-rich region in aENaC, which includes
a PY motif, is able to bind both SH3 and WW domains
[8,12]. Moreover, the proline-rich SH3-binding region of
formin, which does not contain a PY motif, was recently
demonstrated to bind both SH3 and WW domains [13].
Determination of specificity of WW binding is rudimen-
tary. It appears, though, that unlike the WW domains of
Nedd4 and YAP65, which can bind in vitro to the PY
motifs in the sequence GTPPPxY of the Na+ channel 
(b or g ENaC) or WBP1, the dystrophin WW domain 
is unable to bind a similar sequence ([7]; OS and 
DR, unpublished data). Instead, it may bind another
PY-containing peptide (see below).
Structure of WW domains
The primary structure of WW domains has not been pub-
lished yet. However, preliminary NMR structure informa-
tion obtained on the first WW domain of the murine
YAP65 (H Oschkinat, personal communication) indicates
that the domain is a compact module composed essentially
of a three-stranded b sheet (b1–b3), with a turn separating
each b strand, and strands b1 and b2 longer than b3. The
N and C termini of the WW domain are close to each other,
as is typical of a modular domain. The highly conserved
residues of the domain are hydrophobic, and mostly struc-
tural. These include the first highly conserved tryptophan
(located in b1), the phenylalanine/tyrosine (in b2), and the
invariant proline located in the b3 loop (Fig. 2). The
binding surface, composed of segments of the b1 and b3
strands, is shallow and includes the highly conserved tyro-
sine from b2 and the second invariant tryptophan from b3,
both protruding into the binding plane. Interestingly,
although the overall structure of the WW domain does not
resemble that of SH3 domains, the binding surfaces of
both include residues, such as tryptophan and tyrosine,
([11]; H Oschkinat, personal communication) that can form
hydrophobic interactions with prolines. Future peptide
library screens, mutation analysis and structure determina-
tion of WW domains from unrelated proteins (e.g. dystro-
phin, formin-binding proteins) should help in the eluci-
dation of the differences in binding specificity between
the different WW domains.
Function of WW domains 
As the WW domains were first described only recently,
identification of their role in the various proteins which
harbour them is in its infancy. Nevertheless, exciting clues
are emerging, some related to human genetic disorders
such as Liddle’s syndrome or muscular dystrophy.
Liddle’s syndrome is a hereditary form of systemic renal
hypertension. It is characterized by increased Na+ absorp-
tion in the distal nephron [14], which is caused by
increased activity of the epithelial Na+ channel [15].
Recent genetic linkage analyses have demonstrated that
the disease is caused by effective deletion of regions
within the C termini of b [16] or g [17] ENaC, invariably
causing loss of the PY motifs in these subunits. Such dele-
tions lead to increased activity of the channel, which is
probably a result of an increased number of active chan-
nels at the plasma membrane [9,15,18]. We have recently
identified Nedd4 (NPC expressed developmentally
downregulated) as the binding partner for ENaC. Nedd4
[19] contains a C2 domain, 3 (or 4 in the human) WW
domains, and a ubiquitin-ligase HECT (homology to the
E6-AP C terminus) domain (Fig. 1). ENaC–Nedd4 inter-
action is mediated by the WW domains of Nedd4 which
bind to the PY motifs of a, b and g ENaC [8]. Mutations
within the PY motif of b ENaC have been recently identi-
fied in Liddle’s patients [20,21]. These were shown to
cause increased channel activity [9] and to lead to abroga-
tion of Nedd4–WW binding [8]. As Nedd4 contains a
ubiquitin-ligase domain, we speculate that this protein
may be a suppressor of the epithelial Na+ channel; in
Liddle’s syndrome patients, in which Nedd4-binding sites
(PY motifs) in the channel subunits are lost, channel ubiq-
uitination and degradation may be impaired, resulting in
an increased number of active channels at the plasma
membrane. It is interesting that a similar role, involving
regulation of the number of transporters (permeases) at
the plasma membrane, was recently proposed for the yeast
homologue of Nedd4, Rsp5/Npi1 [22].
RSP5, an essential gene in yeast [22], was originally identi-
fied as a suppressor of mutations in the SPT3 gene, a tran-
scription factor interacting with the TATA-binding protein
TFIID [23]; these genetic interactions are likely to be indi-
rect as RSP5 mutations suppress a deletion in SPT3. In
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Figure 1
Schematic representation of several proteins
containing WW domains (red). A single boxed W
(e.g. in DP71 and K01A6.1) represents a portion
of the domain containing either the first or second
conserved tryptophan. The C2 domain (a domain
known to mediate Ca2+-dependent association
with phospholipids/membranes) is found in
Nedd4/Rsp5 and also in PKC, PLA2, PLC,
rasGAP, synaptotagmin I and other proteins. The
HECT domain in Nedd4/Rsp5 and 56G7 is a
ubiquitin ligase (E3) enzyme also present in E6-
AP, the yeast ykl162, rat p100 and UreB1. Pro
represents the proline-rich (SH3 binding) region;
Cys, cysteine rich region; TM, transmembrane
domain of CD45 associated protein (CD45AP);
PH, pleckstrin homology domain also found in
dynamin, SOS, PLCg, IRS-1, rasGAP and Btk;
BCR (breakpoint cluster region) homology
domain, also shared by p85 of PI-3 kinase,
rhoGAP and n-chimerin; PTB/PID domains,
recently suggested to be a subclass of PH
domains, are also present in Shc, numb and IRS-
1; PPIase, peptidylpropyl cis-trans isomerase,
known to associate with transcription factors;
PTP, homologous to protein tyrosine
phosphatases. Actin binding (CH, calponin
homology) domain is homologous to calponin,
actinin, vav and spectrin. In human ORF1
(IQGAP1), the Mp domain is homologous to the
fly muscle protein mp20, and the GTPase
activator is a rasGAP domain. The Y domain,
shared by Yo61 and Ykb2, has no known
function. Sizes of all proteins and domains 
are not to scale.
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Saccharomyces cerevisiae, growth in the presence of a good
nitrogen source (NH4+, glutamine) causes inactivation and
degradation of the general amino acid permease Gap1 [24].
The degradation step is abrogated in RSP5/NPI1 mutant
cells [22]. Moreover, a functional RSP5/NPI1 gene is also
required for stress-induced degradation of the uracil per-
mease Fur4 [22], a process which involves ubiquitination
and endocytosis of the permease, with subsequent degrada-
tion in the vacuoles [25]. This provides an attractive model
in which Rsp5/Npi1 may be involved in permease endo-
cytosis, perhaps via its C2 domain, in an analogy to one of
the C2 domains of synaptotagmin I previously suggested to
play a role in endocytosis [26]. Subsequent ubiquitination
of the internalized permease protein could be mediated by
the HECT domain of Rsp5/Npi1, as speculated above for
the epithelial Na+ channel. Indeed, the Rsp5 [27] and
Nedd4  HECT domains were recently shown to form a
thioester bond with ubiquitin (P Howley, personal commu-
nication), implicating these proteins as functional ubiquitin
ligases. However, unlike ENaC, neither Gap1 nor Fur4
contain a ‘classic’ PY motif [28,29], suggesting that either
Rsp5/Npi1 does not interact directly with these permeases,
or that direct interaction occur via regions other than the
Rsp5 WW domains.
Dystrophin is a large protein absent/mutated in muscles
from patients with Duchenne or Becker muscular dystro-
phy [30]. Its basic structure can be divided into five
regions: an N-terminal actin binding domain, a spectrin-
like domain, a single WW domain, a cysteine-rich domain
and the C-terminal domain (Fig. 1). Dystrophin, located 
at the plasma membrane of skeletal muscles, forms a
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Figure 2
Sequence alignment of WW domains from
different proteins and the suggested WW
consensus sequence. Invariant residues are in
bold letters. Conserved residues in the
consensus sequence are in capital letters;
h represents hydrophobic residues; 
t corresponds to  polar or charged (turn-like)
residues. Boxes under the consensus
sequence indicate location of the b1, b2, and
b3 strands of the WW domain, determined by
H Oschkinat and colleagues (H Oschkinat,
personal communication). Sequences shown
at the bottom of the figure are of putative 
WW domains in which not all of the invariant
amino acids are conserved, or the domain is
split in two. Dots represent spaces introduced
to maximize homology. Dashes (in DP71)
represent an unrelated amino acid sequence.
In the formin-binding proteins FBP11, 21, 
23, 28 and 30, sequences surrounding 
the indicated amino acids [13] have not 
been provided.
Protein/Species Position Sequences of WW domains Accession
number
Nedd4/rat-1           251    PSPLPPGWEERQDVL.GRTYYVNHE........SRTTQWKRPSPEDDLT  U50842
Nedd4/rat-2           407    SSGLPPGWEEKQDDR.GRSYYVDHN........SKTTTWSKPTMQDDPR  U50842
Nedd4/rat-3           464    LGPLPPGWEERTHTD.GRVFFINHN........IKKTQWEDPRMQNVAI  U50842
Nedd4/mouse-1          39    PSPLPPGWEERQDVL.GRTYYVNHE........SRRTQWKRPSPDDDLT  P46935
Nedd4/mouse-2         195    SSGLPPGWEEKQDDR.GRSYYVDHN........SKTTTWSKPTMQDDPR  P46935
Nedd4/mouse-3         250    LGPLPPGWEERTHTD.GRVFFINHN........IKKTQWEDPRLQNVAI  P46935
Nedd4/human-1         217    PSPLPPGWEERQDIL.GRTYYVNHE........SRRTQWKRPTPQDNLT  P46934
Nedd4/human-2         374    SSGLPPGWEEKQDER.GRSYYVDHN........SRTTTWTKPTVQATVE  P46934
Nedd4/human-3         447    QGFLPKGWEVRHAPN.GRPFFIDHN........TKTTTWEDPRLKIPAH  P46934
Nedd4/human-4         499    LGPLPPGWEERTHTD.GRIFYINHN........IKRTQWEDPRLENVAI P46934
Rsp5/yeast-1          228    YGRLPPGWERRTDNF.GRTYYVDHN........TRTTTWKRPTLDQTEA  P39940
Rsp5/yeast-2          330    LGELPSGWEQRFTPE.GRAYFVDHN........TRTTTWVDPRRQQYIR  P39940
Rsp5/yeast-3          386    LGPLPSGWEMRLTNT.ARVYFVDHN........TKTTTWDDPRLPSSLD  P39940
Yap/mouse-1           155    DVPLPAGWEMAKTSS.GQRYFLNHN........DQTTTWQDPRKAMLSQ  P46938
Yap/mouse-2           214    SGPLPDGWEQAMTQD.GEVYYINHK........NKTTSWLDPRLDPRFA  P46938
Yap/human             170    DVPLPAGWEMAKTSS.GQRYFLNHI........DQTTTWQDPRKAMLSQ  P46937
Yap/chicken           168    DVPLPPGWEMAKTPS.GQRYFLNHI........DQTTTWQDPRKAMLSQ  P46936
cl.3544mRNA/mouse      21    TVILPPGWHSYLSPQ.GRRYYVNTT........TNETTWERPSSSPGIS  U19860
F13E6.4/C.elegans 217    QLPMPQGWEMCYDSD.GVRYFKDHN........SKTTTWDDPRLKQQEQ  Z68105
Dodo/drosophila         4    AEQLPDGWEKRTSRSTGMSYYLNMY........TKESQWDQPTEPAKKA  U35140
Ess1/yeast             29    STGLPTPWTARYSKSKKREYFFNPE........TKHSQWEEPEGTNKDQ  P22696
Msb1/human            249     IVLPPNWKTARDPE.GKIYYYHVI........TRQTQWDPPTWESPG      ?
ORF1/human            679    VGDNNSKWVKHWVKG.GYYYYHNLE........TQEGGWDEPPNFVQN   D29640
K01A6.1/C.elegans-1   130    EGLLPPNWETAYTEN.GDKYFIDHN........TGTTTWDDPRELPPGW  Z68750
Fe65/rat               11    DSDLPAGWMRVQDTS.GT.YYWHIP........TGTTQWEPPGRASPSQ  X60468
Ykb2/yeast-1            1        MSIWKEAKDAS.GRIYYYNTL........TKKSTWEKPKELISQE  P33203
Ykb2/yeast-2           38    LLLRENGWKAAKTAD.GKVYYYNPT........TRETSWTIPAFEKKVE  P33203
Dystrophin/human     3954    STSVQGPWERAISPN.KVPYYINHE........TQTTCWDHPKMTELYQ  P11532
DP71/human              8                    -------HE........TQTTCWDHPKMTELYQ  A45255
Utrophin/human       2811    STSVQLPWQRSISHN.KVPYYINHQ........TQTTCWDHPKMTELF   P46939
C38D4.5/C.elegans 95    RRDLLNGWFEYETDV.GRTFFFNKE........TGKSQWIPPRFIRTPA  P46941
P9659.21/yeast          1       MRGEWQEFKTPA.GKKYYYNKN........TKQSRWEKPNLKKGSN  U40829
Yo61/C.elegans-1       77    SPSVESDWSVHTNEK.GTPYYHNRV........TKQTSWIKPDVLKTPL  P34600
Yo61/C.elegans-2      123     QPQQGQWKEFMSDD.GKPYYYNTL........TKKTQWEPPGRASPS   P34600
Yfx1/yeast              8    PPQVPSGWKAVFDDEYQTWYYVDLS........TNSSQWEPPRGTTWPR  P43582
ZK1248.15/C.elegans 198    TENVSPPWKAWWHTEKKRKFYTNDK........TKESLWDHPNTRKNEE  U29244
K015c11/C.elegans ?     QNPDDAWNEFNAPD.GRKYYFNSI........TQENTWEKPKALIDQE  D34959
56G7/C.elegans-1      228    QTPPESHWKTYLDAK.KRKFYVNHV........TKETRWTKPDTLNNNH  Z46793
SPAC13C5.02/S.pombe-1  89    RIPNNDSWVVVFTKK.NRYFFHNLK........SHESYWEPPLEISKDLK Q09685
CD45AP/human           48     TGLALAWRR.LSRD.SGGYYHPARLGAALWGRTRRLLWASPPGRWL    A55412
CD45AP/mouse           48     TALALAWCR.LSHA.SGGYYHPARLGAALWGHTRRLLWASPAGRWL    A49957
FBP11/mouse-1           ?           WTEHKSPD GRTYYYNTE........TKQSTWEKP ?
FBP11/mouse-2           ?           WKEYKSDS.GKPYYYNSQ........TKESRWAKP ?
FBP21/mouse-1           ?           WVEGVTAD.GHCYYYDLI........TGASQWEKP ?
FBP21/mouse-2           ?           WVEGLSED.GYTYYYNTE........TGESKWEKP ?
FBP23/mouse             ?           WVENKTPD.GKVYYYNAR........TRESAWTKP ?
FBP28/mouse             ?           WTEYKTAD.GKTYYYNNR........TLESTWEKP ?
FBP30/mouse             ?           WQEVWDEN.TGCYYYWNTQ.......TNEVTWELP ?
Consensus: LPtGWE   ttt Gt YYhNH.        TtTTtW tPt  t  
V               FF D          S  S
b strands:
Db10/Tobacco            8     PTLPKPWKGLVDGTTGFIYFWNPE........TNDTQYERPVPSSHA   D16247
56G7/C.elegans-2      372    TQPLPSGWE.CITMN.NRTVFLNHA........NKETSFYDPRIRRFET  Z46793
SPAC13C5.02/S.pombe-2   2    SQPLPPGWTEHKAPS.GIPYYWNAE........LKKSTYQRPSFIEKNH  Q09685
YJL168c/yeast         473    RVRLPPGWEIIHENGRP.LYYNAEQ........KTKLHY.PPSGSSKVF  P46995
K01A6.1/C.elegans-2   161    SEGLPPGWEQVDDQNYG.TFYV                             Z68750
270                          NHI........NRKTQYERPYGFGGSS  Z68750
b1 b2 b3
complex with several extracellular, transmembrane and
intracellular proteins, including a group of transmembrane
glycoproteins believed to provide a link between the
extracellular matrix and the actin cytoskeleton. Among
these is the glycoprotein b-dystroglycan. b-dystroglycan
contains several proline-rich regions in its C terminus [31],
including two PY motifs (PLPPPEYP and PYRSPP-
PYVPP). A recent in vitro study [32] has demonstrated
that binding between dystrophin and b-dystroglycan is
mediated by the region encompassing amino acids
3054–3271 (which includes the WW domain and the cys-
teine-rich domain) of dystrophin and the C-terminal final
15 amino acids of b-dystroglycan (KNMTPYRSPP-
PYVPP), which include the above PY motif. These results
suggest that interaction between dystrophin and b-dystro-
glycan is mediated at least in part by the WW domain of
dystrophin and the second PY motif of b-dystroglycan.
Deletions/mutations within the 3′ region of dystrophin
have been associated with severe forms of muscular dys-
trophy, although it is not clear that any of them map to the
WW domain. Nevertheless, the above binding studies [32]
underscore the importance of the WW domain in main-
taining an integral complex between dystrophin and its
associated proteins. Interestingly, a smaller C-terminal
isoform of the dystrophin protein, DP71 (apo-dystrophin),
which is ubiquitously expressed unlike the muscle-
specific dystrophin, lacks the first 19 amino acids of the
WW domain (Figs 1,2). This causes a deletion of the first
highly conserved tryptophan and the double tyrosines (b1
and b2 strands) and presumably renders the DP71 WW
domain nonfunctional. We therefore anticipate reduced or
impaired binding between DP71 and b-dystroglycan.
The role of WW domains in other proteins is not yet
known and can only be speculated. For example, Fe65
[33], a protein homologous to retroviral integrases, is
expressed in the brain and other specific regions of the
nervous system, and contains a WW domain and two
PTB/PID domains. Recently, its PTB/PID domains were
shown to interact with the intracellular domain of the
Alzheimer amyloid precursor protein (APP) by binding to
its NPTY motif [34]. APP is an integral membrane
protein. A small fragment of the protein (amyloid-b-
protein) accumulates in the brain of Alzheimer patients
forming extracellular deposits. Mutations in APP enhance
the production and deposition of amyloid-b-protein. Fe65
may be an adaptor protein which connects APP via the
Fe65–WW domain to an as yet unidentified protein. The
role of Fe65 in the development of Alzheimer’s disease
remains to be demonstrated. Similar adaptor-protein-like
properties have been proposed for YAP65, a yes-kinase
associated phosphoprotein of no known function [35]. 
A proline-rich region in YAP65 associates with the 
SH3 domain of yes and the WW domain of YAP65 binds
in vitro to the PY motifs in WBP1 and WBP2 [7]. It is not
known in which pathway(s) YAP65 is involved, as the
above interactions have not yet been demonstrated 
in vivo. Recently, a WW domain-containing protein that
binds to CD45 (called CD45AP or LPAP) was isolated
[36]. CD45 is a tyrosine phosphatase involved in T-cell
signalling and proliferation. Although the interaction
between CD45 and CD45AP/LPAP is mediated by the
transmembrane domains of both proteins and not by the
WW domain [37,38], it is speculated that CD45AP/LPAP
may bind via its WW domain to other protein(s) important
for CD45 signalling. The Msb1 mutation (mammalian sup-
pressor of bck1) contains a single WW domain and encodes
a suppressor of bck1, a mutant of a yeast MAPKKK (MAP
kinase kinase kinase). It also suppresses mpk1 (a yeast
MAP kinase mutant) [10]. As a PY motif was recently
identified in  MAP kinase-associated protein kinase 2
(MAPKAP2) [10], it is possible that Msb1 may interact via
its WW domain with MAPKAP2, and that this interaction
may contribute to the suppressive effect of Msb1.
Future studies on both the structure and function of 
WW domains will greatly increase our understanding of
the role of this important newly described protein–protein
interaction domain in the function of the various unrelated
proteins that harbour it.
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